Metabolic imaging to assess myocardial viability

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Chronic coronary artery disease (CAD) can cause reversible impairment of heart muscle function.
• This dysfunction is often linked to increased glucose utilization, creating a blood flow-metabolism mismatch.
• Assessing myocardial viability is crucial, especially in patients with poor left ventricular function and heart failure symptoms.

Purpose of the Study:

• To evaluate the accuracy of blood flow-glucose metabolism patterns in predicting myocardial viability.
• To determine the value of PET imaging in identifying high-risk CAD patients.
• To assess the role of PET in stratifying patients for revascularization therapy.

Main Methods:

• Utilized positron emission tomography (PET) to image blood flow and exogenous glucose (18F-deoxyglucose) utilization.
• Assessed 384 dysfunctional myocardial segments in over 107 patients with chronic CAD.
• Correlated imaging findings with myocardial viability, defined by functional recovery after revascularization.

Main Results:

• Established predictive accuracy of blood flow-metabolism patterns against the gold standard of myocardial viability.
• Demonstrated correlations between these patterns and long-term patient survival or cardiac morbidity.
• Highlighted high-risk patient groups benefiting significantly from revascularization, including reduced mortality and improved heart failure symptoms.

Conclusions:

• PET imaging of blood flow and glucose metabolism is valuable for identifying viable myocardium in chronic CAD.
• This technique accurately identifies high-risk patients and guides therapeutic management, particularly revascularization.
• It offers significant benefits for patients with poor left ventricular function and heart failure symptoms.